Biomarkers and treatments of alzheimer’s disease and mild cognitive impairment
Номер патента: ZA202201230B
Опубликовано: 25-09-2024
Автор(ы): Branislav Kovacech, Eva Kontsekova, Michal Novak, Norbert ZILKA
Принадлежит: Axon NeuroScience SE
Опубликовано: 25-09-2024
Автор(ы): Branislav Kovacech, Eva Kontsekova, Michal Novak, Norbert ZILKA
Принадлежит: Axon NeuroScience SE
Реферат: The disclosure provides immunogenic peptides, compositions, means, and methods for treating Alzheimer's disease or mild cognitive impairment. The disclosure turther provides means and methods for diagnosing patients, selecting patients for treatment, and/or evaluating the efficacy of treatment for Alzheimer's disease or mild cognitive impairment
Diagnostic test and treatment/prevention of alzheimer's disease
Номер патента: EP3142708A1. Автор: Arthur P. Bollon,Baoxi Qu. Владелец: Vitruvian Biomedical Inc. Дата публикации: 2017-03-22.